Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Inc
With
Astellas Pharma US, Inc.
A long-term, open label, non-comparative, multi-center study to evaluate the safety of tacrolimus cream-B 0.1% in treating the signs and symptoms of psoriasis.
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of plaque psoriasis
You may not be if
Skin disorder other than plaque psoriasis in the areas to be treated.
